Cite
APA Citation
Mehdi, D. E., Grossi, F. V., Deschatelets, P., Pullon, H., Tan, L., Vega, C. A., & Francois, C. G. (n.d.). aPL-2, a complement C3 inhibitor, may potentially reduce both intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria. Molecular immunology, 89, 115–. http://access.bl.uk/ark:/81055/vdc_100049903415.0x00002e